Bronstein, Gewirtz & Grossman, LLC Is Investigating iRhythm Technologies, Inc. (IRTC) And Encourages Investors to Connect — Neutral
IRTC Accesswire — June 10, 2025NEW YORK CITY, NY / ACCESS Newswire / June 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of iRhythm Technologies, Inc. ("iRhythm" or "the Company") (NASDAQ:IRTC). Investors who purchased iRhythm securities prior to January 11, 2022, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/IRTC.

Bronstein, Gewirtz & Grossman, LLC Encourages FMC Corporation (FMC) Stockholders to Inquire about Securities Investigation — Neutral
FMC Accesswire — June 10, 2025NEW YORK CITY, NY / ACCESS Newswire / June 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of FMC Corporation ("FMC" or "the Company") (NYSE:FMC). Investors who purchased FMC securities prior to November 16, 2023, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/FMC.

Bronstein, Gewirtz & Grossman, LLC Encourages Tempus AI, Inc. (TEM) Shareholders to Inquire about Securities Investigation — Neutral
TEM Accesswire — June 10, 2025NEW YORK CITY, NY / ACCESS Newswire / June 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Tempus AI, Inc. ("Tempus" or "the Company") (NASDAQ:TEM). Investors who purchased Tempus securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/TEM.

Shareholders of Zenas BioPharma, Inc. (ZBIO): Protect Your Rights Before June 16, 2025 - Contact Levi & Korsinsky — Neutral
ZBIO Accesswire — June 10, 2025NEW YORK, NY / ACCESS Newswire / June 10, 2025 / If you suffered a loss on your Zenas BioPharma, Inc. (NASDAQ:ZBIO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/zenas-biopharma-inc-lawsuit-submission-form?prid=152425&wire=1&utm_campaign=21 or contact Joseph E. Levi, Esq.

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Manhattan Associates, Inc. (MANH) and Encourages Stockholders to Learn More About the Investigation — Neutral
MANH Accesswire — June 10, 2025NEW YORK, NY / ACCESS Newswire / June 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Manhattan Associates, Inc. ("Manhattan Associates" or "the Company") (NASDAQ:MANH). Investors who purchased Manhattan Associates securities prior to October 22, 2024, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/MANH.

Bronstein, Gewirtz & Grossman, LLC Is Investigating Luminar Technologies, Inc. (LAZR) And Encourages Shareholders to Connect — Neutral
LAZR Accesswire — June 10, 2025NEW YORK CITY, NY / ACCESS Newswire / June 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Luminar Technologies, Inc. ("Luminar" or "the Company") (NASDAQ:LAZR). Investors who purchased Luminar securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/LAZR.

EdTech Breakthrough Awards Frontline HCM With 2025 “Education Administration Solution of the Year” — Neutral
ROP GlobeNewsWire — June 10, 2025Prestigious International Awards Program Recognizes Outstanding Educational Technology Products and Companies Prestigious International Awards Program Recognizes Outstanding Educational Technology Products and Companies

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ibotta — Neutral
IBTA PRNewsWire — June 10, 2025Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Ibotta To Contact Him Directly To Discuss Their Options If you purchased or otherwise acquired stock of Ibotta (a) pursuant and/or traceable to the registration statement and related prospectus (collectively, the "Registration Statement") issued in connection with Ibotta's April 18, 2024 initial public offering (the "IPO"); (b) purchased or otherwise acquired Ibotta securities between April 18, 2024, and February 26, 2025, inclusive (the "Class Period") and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or …

Ideal Power inks distribution agreement with Kaimei Electronic for Asia — Positive
IPWR Proactive Investors — June 10, 2025Ideal Power Inc (NASDAQ:IPWR) has announced a new distribution partnership with Kaimei Electronic, a leading manufacturer of electrolytic capacitors, resistors, and motor fans. Under the terms of the agreement, Kaimei will distribute Ideal Power's products across Asia.

Cardiovascular Tailwind Boosts BSX: Here's How to Play the Stock — Positive
BSX Zacks Investment Research — June 10, 2025Boston Scientific BSX, a prominent global player in cardiovascular technology, is well-positioned to capitalize on the robust expansion of the cardiovascular devices market. According to a MarketsandMarkets report, this market was valued at $72.83 billion in 2023 and is expected to witness a strong CAGR of 7.3% between 2024 and 2029.

LYB Enters Into Agreement and Negotiations to Sell Assets to AEQUITA — Positive
LYB Zacks Investment Research — June 10, 2025LyondellBasell enters into an agreement and exclusive talks with AEQUITA to sell Europe's four key olefins & polyolefins assets.

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Elevance Health — Neutral
ELV PRNewsWire — June 10, 2025Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Elevance To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Elevance between April 18, 2024 and October 16, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , June 10, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Elevance Health, Inc. ("Elevance" or the …

Liquid Waste Management Sector Sees Surge with Growing Adoption of Decentralized Treatment Systems in Asia-Pacific & Latin America — Neutral
WM GlobeNewsWire — June 10, 2025The Liquid Waste Management Market is driven by rising environmental awareness, strict regulations, and industrial growth, especially in developing regions like Asia-Pacific and Latin America. Opportunities lie in advanced treatment solutions, decentralized systems, and sustainability initiatives, amidst challenges of high costs and infrastructure needs. The Liquid Waste Management Market is driven by rising environmental awareness, strict regulations, and industrial growth, especially in developing regions like Asia-Pacific and Latin America. Opportunities lie in advanced treatment solutions, decentralized systems, and sustainability initiatives, amidst challenges of high costs and infrastructure needs.

Virtu Financial and Limina Team Up to Streamline Post-Trade Operations — Positive
VIRT Zacks Investment Research — June 10, 2025VIRT partners with Limina to streamline post-trade workflows, boost automation and expand its global tech footprint.

What Makes Ouster (OUST) a Good Fit for 'Trend Investing' — Positive
OUST Zacks Investment Research — June 10, 2025Ouster (OUST) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.

Brainsway (BWAY) is on the Move, Here's Why the Trend Could be Sustainable — Positive
BWAY Zacks Investment Research — June 10, 2025Brainsway (BWAY) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.

What Makes Bitcoin Depot Inc. (BTM) a Good Fit for 'Trend Investing' — Positive
BTM Zacks Investment Research — June 10, 2025If you are looking for stocks that are well positioned to maintain their recent uptrend, Bitcoin Depot Inc. (BTM) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

What Makes Perimeter Solutions, SA (PRM) a Good Fit for 'Trend Investing' — Positive
PRM Zacks Investment Research — June 10, 2025Perimeter Solutions, SA (PRM) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.

COD INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In COC To Contact Him Directly To Discuss Their Options — Neutral
CODI PRNewsWire — June 10, 2025Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Compass To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in Compass stock or options between May 1, 2024 and May 7, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Compass Diversified ("Compass" or the "Company") (NYSE: …

Uber set to unleash driverless cars on London next year — Positive
UBER Proactive Investors — June 10, 2025Uber Technologies Inc (NYSE:UBER, ETR:UT8) will launch its first self-driving taxi service in London in 2026 as part of a broader UK trial of autonomous transport, the company and the government announced on Tuesday. The pilot scheme will begin with safety drivers behind the wheel but aims to transition to fully driverless vehicles over time.
